Imagion announces HREC approval for Phase I study
Released
Released
Announcement PDF
®
IMAGION BIOSYSTEMS LIMITED
(ASX: IBX)
7 October 2020
Imagion announces HREC approval for Phase I study
MELBOURNE — Imagion Biosystems (ASX: IBX), a company dedicated to improving healthcare through
the earlier detection of cancer, is pleased to report that it has received approval from the Human Research
Ethics Committee (HREC) for the MagSense™ HER2 Phase I study for metastatic breast cancer. With the
study now approved the Company can proceed with finalising contracts with individual study sites.
Additionally, the Company reports that manufacturing of the MagSense™ HER2 nanoparticle formulation for
the study remains on track, having successfully completed bulk batch production. The company expects to
complete the final step of Good Manufacturing Practice (GMP) compliant packaging of the material on time
to support the start of the study.
Imagion Biosystems Executive Chairman Bob Proulx said, “We are very pleased with our progress and will
now be working diligently with our planned study sites to commence the study this calendar quarter as we
have previously advised.”
-ENDS
About Imagion Biosystems
Imagion Biosystems is developing a new non-radioactive and safe diagnostic imaging technology.
Combining biotechnology and nanotechnology, the Company aims to detect cancer and other diseases
earlier and with higher specificity than is currently possible. Imagion Biosystems listed on the Australian
Securities Exchange (ASX) in June 2017.
For further information please visit www.imagionbiosystems.com
Authorisation & Additional information
This announcement was authorised by the Disclosure Committee of Imagion Biosystems Limited.
U.S. Media Contact:
Matthew Wygant
matthew@biotechwriting.com
+1-408-905-7630
Australian Media & Investor Relations:
Kyahn Williamson, WE Communications
We-AUImagionBiosystems@we-worldwide.com
+61 (0) 401018828
Imagion Biosystems Limited
ACN 616 305 027
Level 25, 525 Collins Street, Melbourne VIC 3000
www.imagionbiosystems.com
Share your feedback
Discover